Risk Factors for Hypoglycemia in Type 2 Diabetes Mellitus Patients Using Once-Weekly Semaglutide: A Matched Case-Control ...
Introduction Glucagon-like peptide-1 (GLP-1) is one of the incretin hormones released from the gut, augmenting insulin secretion. Consequently, it inhibits glucagon secretion, leading to improved glycemic control. It also limits weight gain by inhibiting …